SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
၀.၂၆ US$
arrow_upward
+၁၄.၃၀%(+၀.၀၃၃) 1D
ဇူ ၂၇, GMT-၄ ၁၄:၀၇:၅၁ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
၀.၂၃ US$
High
၀.၂၈ US$
Low
၀.၂၃ US$
Mkt. cap
၁.၃၆ သန်း
Avg. vol.
၅.၉၈ သိန်း
Volume
၆.၀၈ သောင်း
52-wk high
၃.၄၇ US$
52-wk low
၀.၂၁ US$
EPS
-၁.၈၀ US$
Beta
၂.၁၁
Shares outstanding
၃.၉၆ သန်း
No. of employees
၄၅
Open
၀.၂၃ US$
High
၀.၂၈ US$
Low
၀.၂၃ US$
Mkt. cap
၁.၃၆ သန်း
Avg. vol.
၅.၉၈ သိန်း
Volume
၆.၀၈ သောင်း
52-wk high
၃.၄၇ US$
52-wk low
၀.၂၁ US$
EPS
-၁.၈၀ US$
Beta
၂.၁၁
Shares outstanding
၃.၉၆ သန်း
No. of employees
၄၅
News stories
From sources across the web
MarketBeat
·
ပြီးခဲ့သည့် ၄ မိနစ်
Power Solutions International (NASDAQ:PSIX) Hits New 52-Week Low - Here's Why
Yahoo! Finance Canada
·
ပြီးခဲ့သည့် ၁ နာရီ
The perks that S&P 1,500 companies spent $600M on for their CEOs
The Motley Fool
·
ပြီးခဲ့သည့် ၁ နာရီ
Stock Market Midday, July 27: Dow Edges Higher as Nvidia Drop Weighs on Nasdaq
AP News
·
ပြီးခဲ့သည့် ၁ နာရီ
Mediators see progress in efforts to halt Iran war as drone attacks rattle region
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR
AI content may include mistakes. Learn more